Views & Analysis | Perspectives on pharma industry issues

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Articles

Site quality management: the revolution in risk-based monito...

Continuing our clinical trials theme, Joshua Pines and Stephen Young explore site quality management. It is by now well documented that the industry is actively exploring a paradigm shift in its approach to ensuring quality in the conduct of...

Articles

Physician perspectives: Dr Joe Kosterich

Our latest physician perspective is that of Australian physician, Dr Joe Kosterich. Dr Kosterich shares some of the challenges physicians face in using social media and the inspiration behind his website, drjoe.net. There’s a huge focus on health these days, from what foods you should be eating, to how much exercise you should be doing and how much...

Articles

Pharma: part of the problem or part of the solution?

Wendy Blackburn discusses the problems currently facing the pharma industry. “Is pharma part of the problem or part of the solution?” When someone posed this blog post “question” to me, I admit I didn’t know the answer...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital